BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Genetown

  Tetraphase Pharma Added to NASDAQ Biotechnology Index

  The annual re-ranking of the NASDAQ Biotechnology Index will become effective prior to U.S. market open on Monday, December 18, 2017.

  December 15, 2017

   · 

  1 min read
• Policy

  Radius Health Announces that the CHMP Will Issue a Third Day-180 List of Outstanding Issues in its Regulatory Review of Abaloparatide-SC

  Radius Health now anticipates an opinion from the CHMP regarding the MAA for abaloparatide-SC in the first half of 2018.

  December 15, 2017

   · 

  6 min read
• Drug Development

  Orphazyme Assumes Sponsorship of Phase II/III sIBM Trial

  The trial was conceived by expert investigators at KU Medical Center and UCL to assess the efficacy and safety of arimoclomol for the treatment of sIBM.

  December 15, 2017

   · 

  4 min read
• Business

  Resverlogix Announces Filing of Quarterly Financial Statements and Management’s Discussion & Analysis

  Copies of these documents may be obtained online at www.sedar.com, or the Company’s website, www.resverlogix.com, or by emailing ir@resverlogix.com

  December 15, 2017

   · 

  1 min read
• Business

  Mesoblast Grants Tigenix an Exclusive Global Patent License to Use Adipose-Derived Mesenchymal Stem Cells in the Local Treatment of Fistulae

  The agreement includes the right for TiGenix to grant sub-licenses to affiliates and third parties, including TiGenix’s current development and commercialization partner ex-United States.

  December 15, 2017

   · 

  8 min read
• Biotech Bay

  Galena Will Adjourn Special Meeting Until Friday, December 29, 2017, Urges Stockholders to Vote

  The Proxy Statement/Prospectus/Consent Solicitation Statement was previously supplemented by a supplement dated November 29, 2017 and filed with the SEC pursuant to Rule 424(b)(3) on November 30, 2017.

  December 15, 2017

   · 

  4 min read
• Business

  BioDelivery Sciences Reacquires ONSOLIS From Collegium Pharmaceutical

  BDSI and Collegium entered into a license and development agreement for U.S. rights to ONSOLIS in May 2016.

  December 15, 2017

   · 

  4 min read
• Orthocell Granted European Tendon Regeneration Patent

  Regenerative medicine company Orthocell is pleased to announce it has been granted a key European Patent.

  December 15, 2017

   · 

  3 min read
• Drug Development

  ASIT Biotech Reviews the Efficacy Results of gp-ASIT+

  The results presented to the EAACI show that over the course of the whole pollen season, gp-ASIT+ resulted in an average reduction in the combined score of 17.9% for the entire study population, close to the threshold of 20% required by the registration authorities.

  December 15, 2017

   · 

  2 min read
• Business

  Spero Therapeutics Announces 3Q17 Operating Results and Pipeline Update

  The Company reported a net loss of $(12.1) million, or basic and diluted net loss per common share of $(36.02), for the third quarter of 2017.

  December 15, 2017

   · 

  10 min read